English

COLUMBIA LABORATORIES INC

EDGAR

CBRX Filing (4) · filed 2018-08-15

146 filing records in this dataset, filed from 1995-04-14 to 2018-08-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

15.3 million USD

2018 Q2 · USD

Exact inputs and evidence

Revenue: 15310000 USD Source

Operating margin

-12.69%

2018 Q2 · %

Exact inputs and evidence

Operating Income: -1943000 USD Source
Revenue: 15310000 USD Source

Operating cash flow

2.54 million USD

2018 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 1442000 USD Source
Operating Cash Flow: -1101000 USD Source

Free cash flow

326 thousand USD

2018 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 1442000 USD Source
Operating Cash Flow: -1101000 USD Source
Capital Expenditure: 3092000 USD Source
Capital Expenditure: 875000 USD Source

Cash and cash equivalents: 20.8 million USD 2018-06-30 Source
Exact value

20826000 USD
Long-term debt including current maturities: 2.26 million USD 2018-06-30 Source
Exact value

2255000 USD
Shares outstanding: 11.1 million shares 2018-06-30 Source
Exact value

11105000 shares

Reported share-count change

2.41% · 261 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

10844000 shares · 2017-06-30· Source
11105000 shares · 2018-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

55.6 million USD

2017-07-01 – 2018-06-30

Exact inputs and evidence

Revenue: 12986000 USD · 2017-07-01 – 2017-09-30 Source
Revenue: 11790000 USD · 2017-10-01 – 2017-12-31 Source
Revenue: 15524000 USD · 2018-01-01 – 2018-03-31 Source
Revenue: 15310000 USD · 2018-04-01 – 2018-06-30 Source

Net income

-985 thousand USD

2017-07-01 – 2018-06-30

Exact inputs and evidence

Net income: -1410000 USD · 2017-07-01 – 2017-09-30 Source
Net income: 1167000 USD · 2017-10-01 – 2017-12-31 Source
Net income: 772000 USD · 2018-01-01 – 2018-03-31 Source
Net income: -1514000 USD · 2018-04-01 – 2018-06-30 Source

Operating cash flow

3.08 million USD

2017-07-01 – 2018-06-30

Exact inputs and evidence

Operating cash flow: 2233000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 491000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 2127000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 2233000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -1101000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 1442000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -1101000 USD · 2018-01-01 – 2018-03-31 Source

Capital expenditure

4.53 million USD

2017-07-01 – 2018-06-30

Exact inputs and evidence

Capital expenditure: 2404000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 1404000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 2840000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 2404000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 875000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 3092000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 875000 USD · 2018-01-01 – 2018-03-31 Source

Free cash flow

-1.45 million USD

2017-07-01 – 2018-06-30

Exact inputs and evidence

Operating cash flow: 2233000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 491000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 2127000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 2233000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -1101000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 1442000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -1101000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 2404000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 1404000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 2840000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 2404000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 875000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 3092000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 875000 USD · 2018-01-01 – 2018-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-08-15.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2017-12-31
Operating income: 9 of 11 periods available· newest 2017-12-31
Net income: 9 of 11 periods available· newest 2017-12-31
Operating cash flow: 9 of 11 periods available· newest 2017-12-31
Capital expenditure: 9 of 11 periods available· newest 2017-12-31
Total assets: 9 of 11 periods available· newest 2017-12-31
Total liabilities: 9 of 11 periods available· newest 2017-12-31
Current assets: 9 of 11 periods available· newest 2017-12-31
Current liabilities: 9 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2017-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2017-12-31
Shares outstanding: 5 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-8.4%

Prior period

USD 54.57 million

2016-01-01 – 2016-12-31
Current period

USD 49.98 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

49979000 − 54573000 = -4594000 USD

54573000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
49979000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Year-over-year change in Revenue: -4594000 USD Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 49979000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#155393 Filing: 000156459018005087 Input fundies:Revenue: 54573000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#155550 Filing: 000156459018005087
The citation records this snapshot. The page link may show a newer release later.
Net income
-134.6%

Prior period

USD 5.95 million

2016-01-01 – 2016-12-31
Current period

−USD 2.06 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-2060000 − 5951000 = -8011000 USD

5951000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-2060000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Year-over-year change in Net income: -8011000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2060000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#163084 Filing: 000156459018005087 Input fundies:NetIncome: 5951000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#163237 Filing: 000156459018005087
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-81%

Prior period

USD 11.19 million

2016-01-01 – 2016-12-31
Current period

USD 2.13 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

2127000 − 11186000 = -9059000 USD

11186000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
2127000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Year-over-year change in Operating cash flow: -9059000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 2127000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190709 Filing: 000156459018005087 Input fundies:OperatingCashFlow: 11186000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190959 Filing: 000156459018005087
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-20.3%

Prior period

USD 3.56 million

2016-01-01 – 2016-12-31
Current period

USD 2.84 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

2840000 − 3564000 = -724000 USD

3564000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
2840000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Year-over-year change in Capital expenditure: -724000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2840000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191460 Filing: 000156459018005087 Input fundies:CapitalExpenditure: 3564000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191670 Filing: 000156459018005087
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue USD 49.98 million 100% of revenue
Cost of revenue USD 28.96 million 58% of revenue
Operating expenses USD 24.88 million 50% of revenue
Operating income −USD 3.86 million −7.7% of revenue
Tax, interest and other Derived −USD 1.8 million −3.6% of revenue
Net income −USD 2.06 million −4.1% of revenue

Cash

Operating cash flow USD 2.13 million 4.3% of revenue
Capital expenditure USD 2.84 million 5.7% of revenue
Free cash flow Derived −USD 713,000 −1.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 141% of revenue.
2010 Net loss: net income was −48% of revenue.
2011 48%47%
2012 Net income was higher than operating income, so the split is not drawn.
2013 Net income was higher than operating income, so the split is not drawn.
2014 14%86%
2015 Operating loss: operating costs were 105% of revenue.
2016 Net income was higher than operating income, so the split is not drawn.
2017 Operating loss: operating costs were 108% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	32196381	45359828 Derived	-13163447	8706111 Derived	-21869558	-9105520 Derived	Source 2009-01-01 – 2009-12-31: 32196381 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -13163447 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -21869558 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -9055667 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 49853 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	45676297	44502504 Derived	1173793	23004475 Derived	-21830682	-9766021 Derived	Source 2010-01-01 – 2010-12-31: 45676297 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 1173793 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -21830682 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -9723628 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 42393 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	43062021	20133159 Derived	22928862	2401670 Derived	20527192	-2646974 Derived	Source 2011-01-01 – 2011-12-31: 43062021 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 22928862 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 20527192 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -1339871 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 1307103 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	25828000	23019000 Derived	2809000	-7108000 Derived	9917000	3358000 Derived	Source 2012-01-01 – 2012-12-31: 25828000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 2809000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 9917000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 4344000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 986000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	27583000	23351000 Derived	4232000	-509000 Derived	4741000	6551000 Derived	Source 2013-01-01 – 2013-12-31: 27583000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 4232000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 4741000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 7073000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 522000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	33393000	28649000 Derived	4744000	88000 Derived	4656000	4881000 Derived	Source 2014-01-01 – 2014-12-31: 33393000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 4744000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 4656000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 6929000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 2048000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	38287000	40160000 Derived	-1873000	-377000 Derived	-1496000	-2599000 Derived	Source 2015-01-01 – 2015-12-31: 38287000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -1873000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -1496000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -891000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1708000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	54573000	49294000 Derived	5279000	-672000 Derived	5951000	7622000 Derived	Source 2016-01-01 – 2016-12-31: 54573000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 5279000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 5951000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 11186000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 3564000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	49979000	53842000 Derived	-3863000	-1803000 Derived	-2060000	-713000 Derived	Source 2017-01-01 – 2017-12-31: 49979000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -3863000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -2060000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 2127000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2840000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 50M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	32196381	Revenue: 32196381 Open source
20102010-12-31	Revenue	45676297	Revenue: 45676297 Open source
20112011-12-31	Revenue	43062021	Revenue: 43062021 Open source
20122012-12-31	Revenue	25828000	Revenue: 25828000 Open source
20132013-12-31	Revenue	27583000	Revenue: 27583000 Open source
20142014-12-31	Revenue	33393000	Revenue: 33393000 Open source
20152015-12-31	Revenue	38287000	Revenue: 38287000 Open source
20162016-12-31	Revenue	54573000	Revenue: 54573000 Open source
20172017-12-31	Revenue	49979000	Revenue: 49979000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-8.4% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 32196381 Open source
20102010-12-31	Year over year	41.9%	Revenue: 45676297 Open source Revenue: 32196381 Open source
20112011-12-31	Year over year	-5.7%	Revenue: 43062021 Open source Revenue: 45676297 Open source
20122012-12-31	Year over year	-40%	Revenue: 25828000 Open source Revenue: 43062021 Open source
20132013-12-31	Year over year	6.8%	Revenue: 27583000 Open source Revenue: 25828000 Open source
20142014-12-31	Year over year	21.1%	Revenue: 33393000 Open source Revenue: 27583000 Open source
20152015-12-31	Year over year	14.7%	Revenue: 38287000 Open source Revenue: 33393000 Open source
20162016-12-31	Year over year	42.5%	Revenue: 54573000 Open source Revenue: 38287000 Open source
20172017-12-31	Year over year	-8.4%	Revenue: 49979000 Open source Revenue: 54573000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7.7% 2017

Net margin -4.1% 2017

Free cash flow margin -1.4% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-40.9%	Operating Income: -13163447 Open source Revenue: 32196381 Open source
20102010-12-31	Operating margin	2.6%	Operating Income: 1173793 Open source Revenue: 45676297 Open source
20112011-12-31	Operating margin	53.2%	Operating Income: 22928862 Open source Revenue: 43062021 Open source
20122012-12-31	Operating margin	10.9%	Operating Income: 2809000 Open source Revenue: 25828000 Open source
20132013-12-31	Operating margin	15.3%	Operating Income: 4232000 Open source Revenue: 27583000 Open source
20142014-12-31	Operating margin	14.2%	Operating Income: 4744000 Open source Revenue: 33393000 Open source
20152015-12-31	Operating margin	-4.9%	Operating Income: -1873000 Open source Revenue: 38287000 Open source
20162016-12-31	Operating margin	9.7%	Operating Income: 5279000 Open source Revenue: 54573000 Open source
20172017-12-31	Operating margin	-7.7%	Operating Income: -3863000 Open source Revenue: 49979000 Open source
20092009-12-31	Net margin	-67.9%	Net Income: -21869558 Open source Revenue: 32196381 Open source
20102010-12-31	Net margin	-47.8%	Net Income: -21830682 Open source Revenue: 45676297 Open source
20112011-12-31	Net margin	47.7%	Net Income: 20527192 Open source Revenue: 43062021 Open source
20122012-12-31	Net margin	38.4%	Net Income: 9917000 Open source Revenue: 25828000 Open source
20132013-12-31	Net margin	17.2%	Net Income: 4741000 Open source Revenue: 27583000 Open source
20142014-12-31	Net margin	13.9%	Net Income: 4656000 Open source Revenue: 33393000 Open source
20152015-12-31	Net margin	-3.9%	Net Income: -1496000 Open source Revenue: 38287000 Open source
20162016-12-31	Net margin	10.9%	Net Income: 5951000 Open source Revenue: 54573000 Open source
20172017-12-31	Net margin	-4.1%	Net Income: -2060000 Open source Revenue: 49979000 Open source
20092009-12-31	Free cash flow margin	-28.3%	Revenue: 32196381 Open source Operating Cash Flow: -9055667 Open source Capital Expenditure: 49853 Open source
20102010-12-31	Free cash flow margin	-21.4%	Revenue: 45676297 Open source Operating Cash Flow: -9723628 Open source Capital Expenditure: 42393 Open source
20112011-12-31	Free cash flow margin	-6.1%	Revenue: 43062021 Open source Operating Cash Flow: -1339871 Open source Capital Expenditure: 1307103 Open source
20122012-12-31	Free cash flow margin	13%	Revenue: 25828000 Open source Operating Cash Flow: 4344000 Open source Capital Expenditure: 986000 Open source
20132013-12-31	Free cash flow margin	23.8%	Revenue: 27583000 Open source Operating Cash Flow: 7073000 Open source Capital Expenditure: 522000 Open source
20142014-12-31	Free cash flow margin	14.6%	Revenue: 33393000 Open source Operating Cash Flow: 6929000 Open source Capital Expenditure: 2048000 Open source
20152015-12-31	Free cash flow margin	-6.8%	Revenue: 38287000 Open source Operating Cash Flow: -891000 Open source Capital Expenditure: 1708000 Open source
20162016-12-31	Free cash flow margin	14%	Revenue: 54573000 Open source Operating Cash Flow: 11186000 Open source Capital Expenditure: 3564000 Open source
20172017-12-31	Free cash flow margin	-1.4%	Revenue: 49979000 Open source Operating Cash Flow: 2127000 Open source Capital Expenditure: 2840000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 2.1M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	-9055667	Operating Cash Flow: -9055667 Open source
20102010-12-31	Operating cash flow	-9723628	Operating Cash Flow: -9723628 Open source
20112011-12-31	Operating cash flow	-1339871	Operating Cash Flow: -1339871 Open source
20122012-12-31	Operating cash flow	4344000	Operating Cash Flow: 4344000 Open source
20132013-12-31	Operating cash flow	7073000	Operating Cash Flow: 7073000 Open source
20142014-12-31	Operating cash flow	6929000	Operating Cash Flow: 6929000 Open source
20152015-12-31	Operating cash flow	-891000	Operating Cash Flow: -891000 Open source
20162016-12-31	Operating cash flow	11186000	Operating Cash Flow: 11186000 Open source
20172017-12-31	Operating cash flow	2127000	Operating Cash Flow: 2127000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -713K 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	-9105520	Operating Cash Flow: -9055667 Open source Capital Expenditure: 49853 Open source
20102010-12-31	Free cash flow	-9766021	Operating Cash Flow: -9723628 Open source Capital Expenditure: 42393 Open source
20112011-12-31	Free cash flow	-2646974	Operating Cash Flow: -1339871 Open source Capital Expenditure: 1307103 Open source
20122012-12-31	Free cash flow	3358000	Operating Cash Flow: 4344000 Open source Capital Expenditure: 986000 Open source
20132013-12-31	Free cash flow	6551000	Operating Cash Flow: 7073000 Open source Capital Expenditure: 522000 Open source
20142014-12-31	Free cash flow	4881000	Operating Cash Flow: 6929000 Open source Capital Expenditure: 2048000 Open source
20152015-12-31	Free cash flow	-2599000	Operating Cash Flow: -891000 Open source Capital Expenditure: 1708000 Open source
20162016-12-31	Free cash flow	7622000	Operating Cash Flow: 11186000 Open source Capital Expenditure: 3564000 Open source
20172017-12-31	Free cash flow	-713000	Operating Cash Flow: 2127000 Open source Capital Expenditure: 2840000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

32.2% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Liabilities / assets	139.4%	Total Liabilities: 60981529 Open source Total Assets: 43757219 Open source
20102010-12-31	Liabilities / assets	166.7%	Total Liabilities: 49772348 Open source Total Assets: 29858842 Open source
20112011-12-31	Liabilities / assets	41.2%	Total Liabilities: 14851779 Open source Total Assets: 36082586 Open source
20122012-12-31	Liabilities / assets	13.4%	Total Liabilities: 4953207 Open source Total Assets: 36868664 Open source
20132013-12-31	Liabilities / assets	21.1%	Total Liabilities: 12664000 Open source Total Assets: 60092000 Open source
20142014-12-31	Liabilities / assets	27.5%	Total Liabilities: 14333000 Open source Total Assets: 52208000 Open source
20152015-12-31	Liabilities / assets	26.7%	Total Liabilities: 13515000 Open source Total Assets: 50577000 Open source
20162016-12-31	Liabilities / assets	30%	Total Liabilities: 17251000 Open source Total Assets: 57571000 Open source
20172017-12-31	Liabilities / assets	32.2%	Total Liabilities: 19708000 Open source Total Assets: 61220000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.2× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	2.7×	Current Assets: 22650713 Open source Current Liabilities: 8395076 Open source
20102010-12-31	Current assets / current liabilities	1.07×	Current Assets: 28856159 Open source Current Liabilities: 26859423 Open source
20112011-12-31	Current assets / current liabilities	5.14×	Current Assets: 34137229 Open source Current Liabilities: 6636517 Open source
20122012-12-31	Current assets / current liabilities	9.58×	Current Assets: 35902555 Open source Current Liabilities: 3745934 Open source
20132013-12-31	Current assets / current liabilities	5.12×	Current Assets: 32227000 Open source Current Liabilities: 6297000 Open source
20142014-12-31	Current assets / current liabilities	2.78×	Current Assets: 26386000 Open source Current Liabilities: 9491000 Open source
20152015-12-31	Current assets / current liabilities	2.64×	Current Assets: 25934000 Open source Current Liabilities: 9839000 Open source
20162016-12-31	Current assets / current liabilities	2.32×	Current Assets: 34727000 Open source Current Liabilities: 14992000 Open source
20172017-12-31	Current assets / current liabilities	2.2×	Current Assets: 35973000 Open source Current Liabilities: 16340000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 21.87 million Exact value Exact value: -21869558 USD 2009-01-01 – 2009-12-31: -21869558 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2009-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: -21869558 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21869558 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199512000022/cbrx-20111231.xml#351667 Filing: 000082199512000022 The citation records this snapshot. The page link may show a newer release later.	−USD 9.06 million Exact value Exact value: -9055667 USD 2009-01-01 – 2009-12-31: -9055667 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2009-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: -9055667 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9055667 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199512000022/cbrx-20111231.xml#350896 Filing: 000082199512000022 The citation records this snapshot. The page link may show a newer release later.	USD 49,853 Exact value Exact value: 49853 USD 2009-01-01 – 2009-12-31: 49853 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2009-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 49853 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49853 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199512000022/cbrx-20111231.xml#365777 Filing: 000082199512000022 The citation records this snapshot. The page link may show a newer release later.	−USD 9.11 million Calculation and evidence -9055667 − 49853 USD Exact free cash flow: -9105520 USD 2009-01-01 – 2009-12-31: -9055667 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 49853 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2009-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: -9105520 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9055667 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199512000022/cbrx-20111231.xml#350896 Filing: 000082199512000022 Input fundies:CapitalExpenditure: 49853 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199512000022/cbrx-20111231.xml#365777 Filing: 000082199512000022 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 21.83 million Exact value Exact value: -21830682 USD 2010-01-01 – 2010-12-31: -21830682 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2010-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: -21830682 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21830682 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199513000014/cbrx-20121231.xml#629493 Filing: 000082199513000014 The citation records this snapshot. The page link may show a newer release later.	−USD 9.72 million Exact value Exact value: -9723628 USD 2010-01-01 – 2010-12-31: -9723628 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2010-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: -9723628 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9723628 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199513000014/cbrx-20121231.xml#628989 Filing: 000082199513000014 The citation records this snapshot. The page link may show a newer release later.	USD 42,393 Exact value Exact value: 42393 USD 2010-01-01 – 2010-12-31: 42393 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2010-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 42393 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42393 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199513000014/cbrx-20121231.xml#651254 Filing: 000082199513000014 The citation records this snapshot. The page link may show a newer release later.	−USD 9.77 million Calculation and evidence -9723628 − 42393 USD Exact free cash flow: -9766021 USD 2010-01-01 – 2010-12-31: -9723628 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 42393 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2010-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: -9766021 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9723628 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199513000014/cbrx-20121231.xml#628989 Filing: 000082199513000014 Input fundies:CapitalExpenditure: 42393 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000082199513000014/cbrx-20121231.xml#651254 Filing: 000082199513000014 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 20.53 million Exact value Exact value: 20527192 USD 2011-01-01 – 2011-12-31: 20527192 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2011-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: 20527192 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 20527192 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312514084454/cbrx-20131231.xml#128635 Filing: 000119312514084454 The citation records this snapshot. The page link may show a newer release later.	−USD 1.34 million Exact value Exact value: -1339871 USD 2011-01-01 – 2011-12-31: -1339871 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2011-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: -1339871 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1339871 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312514084454/cbrx-20131231.xml#119868 Filing: 000119312514084454 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1307103 USD 2011-01-01 – 2011-12-31: 1307103 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2011-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 1307103 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1307103 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312514084454/cbrx-20131231.xml#131408 Filing: 000119312514084454 The citation records this snapshot. The page link may show a newer release later.	−USD 2.65 million Calculation and evidence -1339871 − 1307103 USD Exact free cash flow: -2646974 USD 2011-01-01 – 2011-12-31: -1339871 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1307103 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2011-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: -2646974 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1339871 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312514084454/cbrx-20131231.xml#119868 Filing: 000119312514084454 Input fundies:CapitalExpenditure: 1307103 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312514084454/cbrx-20131231.xml#131408 Filing: 000119312514084454 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 9.92 million Exact value Exact value: 9917000 USD 2012-01-01 – 2012-12-31: 9917000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2012-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: 9917000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9917000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312515096081/cbrx-20141231.xml#1591290 Filing: 000119312515096081 The citation records this snapshot. The page link may show a newer release later.	USD 4.34 million Exact value Exact value: 4344000 USD 2012-01-01 – 2012-12-31: 4344000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2012-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: 4344000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4344000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312515096081/cbrx-20141231.xml#1577886 Filing: 000119312515096081 The citation records this snapshot. The page link may show a newer release later.	USD 986,000 Exact value Exact value: 986000 USD 2012-01-01 – 2012-12-31: 986000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2012-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 986000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 986000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312515096081/cbrx-20141231.xml#1590750 Filing: 000119312515096081 The citation records this snapshot. The page link may show a newer release later.	USD 3.36 million Calculation and evidence 4344000 − 986000 USD Exact free cash flow: 3358000 USD 2012-01-01 – 2012-12-31: 4344000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 986000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2012-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: 3358000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4344000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312515096081/cbrx-20141231.xml#1577886 Filing: 000119312515096081 Input fundies:CapitalExpenditure: 986000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312515096081/cbrx-20141231.xml#1590750 Filing: 000119312515096081 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 4.74 million Exact value Exact value: 4741000 USD 2013-01-01 – 2013-12-31: 4741000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2013-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: 4741000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4741000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312516767847/jnp-20151231.xml#106178 Filing: 000119312516767847 The citation records this snapshot. The page link may show a newer release later.	USD 7.07 million Exact value Exact value: 7073000 USD 2013-01-01 – 2013-12-31: 7073000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2013-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: 7073000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7073000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312516767847/jnp-20151231.xml#100807 Filing: 000119312516767847 The citation records this snapshot. The page link may show a newer release later.	USD 522,000 Exact value Exact value: 522000 USD 2013-01-01 – 2013-12-31: 522000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2013-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 522000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 522000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312516767847/jnp-20151231.xml#105912 Filing: 000119312516767847 The citation records this snapshot. The page link may show a newer release later.	USD 6.55 million Calculation and evidence 7073000 − 522000 USD Exact free cash flow: 6551000 USD 2013-01-01 – 2013-12-31: 7073000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 522000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2013-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: 6551000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7073000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312516767847/jnp-20151231.xml#100807 Filing: 000119312516767847 Input fundies:CapitalExpenditure: 522000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000119312516767847/jnp-20151231.xml#105912 Filing: 000119312516767847 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 4.66 million Exact value Exact value: 4656000 USD 2014-01-01 – 2014-12-31: 4656000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2014-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: 4656000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4656000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459017003520/jnp-20161231.xml#153660 Filing: 000156459017003520 The citation records this snapshot. The page link may show a newer release later.	USD 6.93 million Exact value Exact value: 6929000 USD 2014-01-01 – 2014-12-31: 6929000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2014-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: 6929000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6929000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459017003520/jnp-20161231.xml#180652 Filing: 000156459017003520 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2048000 USD 2014-01-01 – 2014-12-31: 2048000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2014-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 2048000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2048000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459017003520/jnp-20161231.xml#181322 Filing: 000156459017003520 The citation records this snapshot. The page link may show a newer release later.	USD 4.88 million Calculation and evidence 6929000 − 2048000 USD Exact free cash flow: 4881000 USD 2014-01-01 – 2014-12-31: 6929000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 2048000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2014-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: 4881000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6929000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459017003520/jnp-20161231.xml#180652 Filing: 000156459017003520 Input fundies:CapitalExpenditure: 2048000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459017003520/jnp-20161231.xml#181322 Filing: 000156459017003520 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 1.5 million Exact value Exact value: -1496000 USD 2015-01-01 – 2015-12-31: -1496000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2015-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: -1496000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1496000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#163389 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	−USD 891,000 Exact value Exact value: -891000 USD 2015-01-01 – 2015-12-31: -891000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2015-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: -891000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -891000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191210 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 1.71 million Exact value Exact value: 1708000 USD 2015-01-01 – 2015-12-31: 1708000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2015-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 1708000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1708000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191880 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	−USD 2.6 million Calculation and evidence -891000 − 1708000 USD Exact free cash flow: -2599000 USD 2015-01-01 – 2015-12-31: -891000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1708000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2015-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: -2599000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -891000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191210 Filing: 000156459018005087 Input fundies:CapitalExpenditure: 1708000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191880 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 5.95 million Exact value Exact value: 5951000 USD 2016-01-01 – 2016-12-31: 5951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2016-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: 5951000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5951000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#163237 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 11.19 million Exact value Exact value: 11186000 USD 2016-01-01 – 2016-12-31: 11186000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2016-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: 11186000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11186000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190959 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 3.56 million Exact value Exact value: 3564000 USD 2016-01-01 – 2016-12-31: 3564000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2016-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 3564000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3564000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191670 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 7.62 million Calculation and evidence 11186000 − 3564000 USD Exact free cash flow: 7622000 USD 2016-01-01 – 2016-12-31: 11186000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 3564000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2016-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: 7622000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11186000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190959 Filing: 000156459018005087 Input fundies:CapitalExpenditure: 3564000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191670 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 2.06 million Exact value Exact value: -2060000 USD 2017-01-01 – 2017-12-31: -2060000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Net Income: -2060000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2060000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#163084 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 2.13 million Exact value Exact value: 2127000 USD 2017-01-01 – 2017-12-31: 2127000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Operating Cash Flow: 2127000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2127000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190709 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	USD 2.84 million Exact value Exact value: 2840000 USD 2017-01-01 – 2017-12-31: 2840000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Capital Expenditure: 2840000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2840000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191460 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.	−USD 713,000 Calculation and evidence 2127000 − 2840000 USD Exact free cash flow: -713000 USD 2017-01-01 – 2017-12-31: 2127000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2840000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COLUMBIA LABORATORIES INC · 2017-12-31 COLUMBIA LABORATORIES INC (edgar:821995) Free cash flow: -713000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:52:45Z Snapshot: aaae1627888d70eaaaa499d8bad5835d60fca6db9bd30e156b78744332ff8558 Dimensions: Consolidated View: https://fundies.io/companies/edgar/821995?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2127000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#190709 Filing: 000156459018005087 Input fundies:CapitalExpenditure: 2840000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/821995/000156459018005087/jnp-20171231.xml#191460 Filing: 000156459018005087 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

146 filings · 3,107 latest values · 3,107 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000821995, 821995, CBRX, JNP, edgar:821995

Also known as COLUMBIA LABORATORIES INC, Columbia Laboratories Inc, JUNIPER PHARMACEUTICALS INC

COLUMBIA LABORATORIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation